Trend in Hospital Lengths of Stay and Readmissions (ELIPSE)

April 5, 2017 updated by: Hospices Civils de Lyon

Association Between Trend in Length of Stay and Risk of Readmission at Hospital After Surgery

Medical and surgical innovations have allowed to shorter length of hospital stay (LOS). We assume that hospitals with uncontrolled reduction in LOS may expose patients to unsafe care. At the institutional level, a dynamic analysis of LOS evolution over time could clarify the existence of a link with the risk of readmission.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

100000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Lyon, France, 69424
        • Recruiting
        • Pôle Information Médicale Evaluation Recherche des Hospices Civils de Lyon
        • Contact:
        • Principal Investigator:
          • Antoine DUCLOS, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients operated for colorectal disease or hip fracture

Description

Inclusion Criteria:

  • All patients who underwent elective colorectal surgery or urgent surgical procedure for hip fracture in French public and private hospitals from January 2014 to December 2016

Exclusion Criteria:

  • Age < 18 years old
  • Death during the index stay

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Colorectal surgery
Patient who underwent elective colorectal surgery
Other: Hospital stay
Collection of hospital lengths of stay and readmissions
Hip fracture
Patient who underwent urgent surgical procedure for hip fracture
Other: Hospital stay
Collection of hospital lengths of stay and readmissions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Unplanned hospital readmission with death, intensive care, or reoperation
Time Frame: 30 days
Number of unplanned hospital readmission with death, intensive care, or reoperation within 30 days of surgical procedure
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Unplanned hospital readmission with death, intensive care, or reoperation
Time Frame: 3 months
Number of unplanned hospital readmission with death, intensive care, or reoperation within 3 months of surgical procedure
3 months
Unplanned hospital readmission with death, intensive care, or reoperation
Time Frame: 6 months
Number of unplanned hospital readmission with death, intensive care, or reoperation within 6 months of surgical procedure
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospices Civils de Lyon

Investigators

  • Principal Investigator: Antoine DUCLOS, MD, PhD, Pôle Information Médicale Evaluation Recherche des Hospices Civils de Lyon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 21, 2017

Primary Completion (Anticipated)

March 1, 2018

Study Completion (Anticipated)

May 1, 2018

Study Registration Dates

First Submitted

April 5, 2017

First Submitted That Met QC Criteria

April 5, 2017

First Posted (Actual)

April 11, 2017

Study Record Updates

Last Update Posted (Actual)

April 11, 2017

Last Update Submitted That Met QC Criteria

April 5, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 69HCL17_0036

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trend in Hospital Lengths of Stay and Readmissions

Clinical Trials on Hospital stay

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe